A critical review of the pharmacology of the plant extract of Pygeum africanum in the treatment of LUTS
- 18 June 2007
- journal article
- review article
- Published by Wiley in Neurourology and Urodynamics
- Vol. 26 (4) , 458-463
Abstract
Despite an unremitting increase in the number of patients presenting symptoms of benign prostate hyperplasia (BPH), the viable treatment options remain relatively limited when compared to other disorders of aging. This has spurred an interest in so‐called alternative medicines, many of which continue to be used in spite of the more recent emergence of rationally targeted therapies. Nonetheless, in the case of plant extracts, the vast majority of these have not been subjected to the same rigorous pre‐clinical pharmacological testing and large‐scale clinical trials now required by health authorities. Furthermore, demonstration of their clinical efficacy in BPH has been hindered by trials of limited duration with a high placebo response. Beginning with a preliminary demonstration of in vitro inhibition of growth factor‐mediated fibroblast proliferation with Pygeum africanum extract, a detailed series of in vitro and in vivo studies on prostate growth and bladder function were undertaken. These studies, reviewed herein, have permitted the identification of putative molecular targets of Pygeum africanum extract affecting both growth factor‐mediated prostate growth as well as specific parameters of bladder function. These results, corroborated in part by short‐term clinical efficacy, set the stage for a large‐scale clinical trial to investigate the efficacy of Pygeum africanum extract in the treatment of lower urinary tract symptoms. Neurourol. Urodynam. 26:458–463, 2007.Keywords
This publication has 32 references indexed in Scilit:
- Focal hypoxia of the obstructed rabbit bladder wall correlates with intermediate decompensationNeurourology and Urodynamics, 2003
- Effect of Oral Tadenan Treatment on Rabbit Bladder Structure and Function After Partial Outlet ObstructionJournal of Urology, 2002
- IMPROVED CONTRACTILITY OF OBSTRUCTED BLADDERS AFTER TADENAN TREATMENT IS ASSOCIATED WITH REVERSAL OF ALTERED MYOSIN ISOFORM EXPRESSIONJournal of Urology, 2000
- Apoptosis and Benign Prostatic HypertrophyJournal of Urology, 1997
- Antiproliferative Effect of Pygeum Africanum Extract on Rat Prostatic FibroblastsJournal of Urology, 1997
- Correlations between Parameters in Pressure-Flow Analysis and Histological Compositions in Prostate in Patients with Benign Prostatic HyperplasiaUrologia Internationalis, 1997
- Phytotherapy for the prostateBritish Journal of Urology, 1996
- Protective Effect of Tadenan of Bladder Function Secondary to Partial Outlet ObstructionJournal of Urology, 1996
- Early molecular response to rabbit bladder outlet obstructionNeurourology and Urodynamics, 1992
- Effect of bladder outlet obstruction on the morphology, physiology, and pharmacology of the bladderThe Prostate, 1990